Product
CRS Mitigation Strategies
1 clinical trial
1 indication
Indication
Small Cell Lung CarcinomaClinical trial
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Tarlatamab in Subjects With Small Cell Lung Cancer (DeLLphi-300)Status: Recruiting, Estimated PCD: 2024-10-22